Latest News
Conference Coverage
Biosimilars: No big dollar savings, but are clinically ‘dead on’
SNOWMASS, COLO. – Cost savings seen with biosimilars in European countries won’t happen in the United States, but studies are beginning to show...
News
Psoriasis and depression may pack a PsA punch
What role might depression play in development of psoriatic arthritis?
News
Humira Pen topped per-person drug spending in 2016
The spending top 10 includes three drugs for diabetes, two for arthritis/psoriasis, and two for multiple sclerosis.
News
Psoriatic arthritis raises diabetes risk
Psoriatic arthritis boosts the risk of diabetes, with higher disease activity magnifying that effect.
News
Perioperative infliximab does not increase serious infection risk
The timing of a last dose of infliximab prior to elective knee or hip replacement surgery does not appear to affect the 30-day risk of serious...
News
FDA opens abbreviated approval pathway for interchangeable biosimilars
The FDA has proposed a regulatory path for biosimilar biologics that are interchangeable with the reference product.
News
Bone fractures more likely to occur in psoriasis, PsA patients
This is the first population-based study to examine the relationship between bone fractures and psoriasis, according to the authors.
News
Symptoms don’t worsen during pregnancy in most PsA patients
Many patients benefit from better skin, although flares may come.
Article
Medicare payments set for infliximab biosimilar Inflectra
Medicare will now cover payment for the infliximab biosimilar drug Inflectra.
Conference Coverage
VIDEO: Statins cut mortality in ankylosing spondylitis, psoriatic arthritis
Statins appear to cut mortality in ankylosing spondylitis and psoriatic arthritis.